Gastroenterology Research and Practice / 2017 / Article / Tab 2

Research Article

Safety and Efficacy of Exclusive Enteral Nutrition for Percutaneously Undrainable Abdominal Abscesses in Crohn’s Disease

Table 2

Univariate analysis of potential predictors for surgery in CD patients with percutaneously undrainable abscesses.

Variable1-year cumulative surgical rate (%) (log-rank)

Gender0.972
Male87.2
Female83.3

Age at diagnosis0.895
A1 (16 years)0
A2 (17–40 years)86.2
A3 (40 years)84.0

Disease location0.208
L1 (ileal)85.7
L2 (colonic)100.0
L3 (ileocolonic)84.6

Steroids use at diagnosis0.703
No86.3
Yes84.4

AZA/6-MP use at diagnosis0.550
No89.8
Yes79.4

Infliximab use at diagnosis0.360
No87.7
Yes70.0

Perianal lesion0.922
No85.5
Yes85.7

Previous abdominal surgery0.007
No81.2
Yes100.0

Abscess diameter > 3 cm0.006
No80.3
Yes100

Fistula0.928
No85.4
Yes85.7

Multiple abscesses0.060
No82.4
Yes100

Abscess location0.253
Right lower quadrant83.8
Pelvis88.0
Others85.7

Exclusive enteral nutrition0.001
No96.6
Yes79.6

AZA: azathioprine; 6-MP: mercaptopurine.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.